Cabergoline

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Biochem/physiol Actions Cabergoline, a lysergic acid amide derivative, is a potent dopamine D2 receptor agonist. It also acts on dopamine receptors in lactophilic hypothalamus cells to suppress prolactin production in the pituitary gland.

Biochem/physiol Actions Cabergoline, a lysergic acid amide derivative, is a potent dopamine D2 receptor agonist. It also acts on dopamine receptors in lactophilic hypothalamus cells to suppress prolactin production in the pituitary gland.

Chemical structure: nucleoside Biochem/physiol Actions Cordycepin is an adenosine analogue that is readily converted to cordycepin 5&#8242-triphosphate can be used for 3&#8242-end labeling of RNA. Features and Benefits This compound is a

Chemical structure: nucleoside Biochem/physiol Actions Cordycepin is an adenosine analogue that is readily converted to cordycepin 5&#8242-triphosphate can be used for 3&#8242-end labeling of RNA. Features and Benefits This compound is a

Chemical structure: nucleoside Biochem/physiol Actions Cordycepin is an adenosine analogue that is readily converted to cordycepin 5&#8242-triphosphate can be used for 3&#8242-end labeling of RNA. Features and Benefits This compound is a

MF: C20H24O11 MF: 440.41 CAS: 15291-76-6 Purity: >98% by HPLC

Taxifolin is a plant flavonoid , which may find applications in the treatment of coronary heart disease, angina pectoris, cerebral thrombosis, cerebral infarction and sequelae. Application Refer to the product&#8242s Certificate of Analysis for

Taxifolin is a plant flavonoid , which may find applications in the treatment of coronary heart disease, angina pectoris, cerebral thrombosis, cerebral infarction and sequelae. Application Refer to the product&#8242s Certificate of Analysis for